b12-labs.com

What It Is

b12 labs is an AI-driven chemical synthesis platform designed to move drug and biotech R&D workflows from “target molecule” to “physical product.” According to its website, it covers route planning, condition optimization, robotic experiment execution, result analysis, and commissioned synthesis services. Its core products include Selenium, Palladium, Cobalt, and Cloud Reactions.

Core Capabilities

Selenium handles retrosynthetic planning: after a target molecule is entered, the system evaluates synthesis strategies, builds a route tree, and outputs ranked routes, specific steps, and predicted yields. Palladium focuses on reaction condition optimization, designing combinations of catalysts, ligands, bases, solvents, and more within a single screening plate, while incorporating literature priors and users’ own data. Cobalt converts optimized conditions into executable protocols for automation platforms such as Chemspeed and Opentrons, with an emphasis on no-code operation. The platform also mentions peak detection, byproduct prediction, and impurity analysis for raw HPLC-MS and NMR data, using those results to propose conditions for the next round of experiments.

Pricing and Trial

The site provides entry points such as Get Started, Request a Demo, Try Selenium, Try Palladium, and Try Cobalt, and says that self-service software is available immediately at app.b12-labs.com. However, the captured content does not disclose any free tier, subscription pricing, usage-based billing, or specific quotes for synthesis services. Cloud Reactions/synthesis services appear to be evaluated individually based on the chemistry problem, scale, and analytical requirements.

Pros and Cons

Its main strength is the completeness of the workflow: from retrosynthesis and HTE plate design to robotic execution and analytical feedback, it is better suited to complex molecules and multi-step routes rather than simple library synthesis. The ability to describe intent in natural language and automatically generate protocols is friendly to chemists who are not familiar with automation programming. The downside is that the website is quite product-oriented and provides limited detail on model sources, validation sets, failure boundaries, data privacy, IP ownership, and enterprise compliance. The stated efficiency and yield metrics also lack clear third-party validation context.

Who It’s For and Access from China

It is better suited to pharmaceutical companies, biotech firms, CROs/internal synthesis teams, and R&D organizations that already have or plan to use lab automation equipment. It is not a good match for users who only need general AI writing tools or simple molecular library procurement. Access from mainland China, payment methods, Chinese-language support, and local delivery capabilities are not explained in the main content, so they should be considered unknown for now. For deployment in China, users should pay particular attention to network availability, cross-border data compliance, compound data confidentiality, and backup supplier options.